Skip to main content
. 2021 Jan;10(1):304–313. doi: 10.21037/tlcr-20-380

Figure 1.

Figure 1

PLS-DA blot of significant metabolic differences between non-small cell lung cancer (NSCLC) patients and healthy controls. PLS-DA, partial least squares discriminant analysis.